CN101209322A - 'Chuierbaoting' powder - Google Patents

'Chuierbaoting' powder Download PDF

Info

Publication number
CN101209322A
CN101209322A CNA2007101441035A CN200710144103A CN101209322A CN 101209322 A CN101209322 A CN 101209322A CN A2007101441035 A CNA2007101441035 A CN A2007101441035A CN 200710144103 A CN200710144103 A CN 200710144103A CN 101209322 A CN101209322 A CN 101209322A
Authority
CN
China
Prior art keywords
radix
chuierbaoting
powder
moschus
pulvis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CNA2007101441035A
Other languages
Chinese (zh)
Other versions
CN101209322B (en
Inventor
周鑫
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2007101441035A priority Critical patent/CN101209322B/en
Publication of CN101209322A publication Critical patent/CN101209322A/en
Application granted granted Critical
Publication of CN101209322B publication Critical patent/CN101209322B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a medical prepared product containing the reaction product which derives from plant materials, in particular to a ChuiErBaoTing pulvis used for treating acute and chronic otitis media. The technical proposal adopted by the invention is that the invention is the preparation prepared by the following ingredients by weight: 4-9g of divaricate saposhnikovia root, 4-9g of forsythia, 4-9g of angelica dahurica, 4-9g of honeysuckle, 4-9g of heartleaf houttuynia herb, 2-6g of balloon flower, 4-9g of radix bupleuri, 8-12g of radix scutellariae, 2-6g of grassleaf sweelflag rhizome and 0.3-1g of muskiness. The beneficial effects of the invention are that: the invention is a pure Chinese medicine external pulvis, ChuiErBaoTing pulvis, which is developed by being based on the basic theory of the traditional Chinese medicine and combining clinical practice. The invention adopts the therapeutic principle of clearing away heat and toxic material, converging fluid and diminishing inflammation, thus achieving better curative effect. Proved by long-term clinical practice, the invention is characterized by significant curative effect, safe usage, no pain, no wound and so on, and is economical and convenient for administration of common people; therefore, the invention is worthy of popularization.

Description

'Chuierbaoting ' powder
Technical field
The present invention relates to contain the medicinal preparation that derives from the vegetable material product, especially belong to a kind of 'Chuierbaoting ' powder for the treatment of the acute and chronic otitis media.
Background technology
Otitis media is a kind of common otopathy, the general normal child below 8 years old that betides well.It often is the pain complication that upper respiratory tract infection caused such as common cold or throat infection.At present, adopt western medicine for the treatment of otitis media more, the employing Chinese traditional treatment that also has, but curative effect still can not be satisfactory, and therefore, Chinese and western medicine all lacks a kind of effective Therapeutic Method to this disease.
Summary of the invention
The object of the present invention is to provide a kind of easy, economical, have no side effect and directly be blown into the 'Chuierbaoting ' powder of the treatment acute and chronic otitis media of earhole.
The technical solution used in the present invention is: it is that one-tenth by following weight ratio is distributed into medicament:
Radix Saposhnikoviae 4-9g Fructus Forsythiae 4-9g Radix Angelicae Dahuricae 4-9g Flos Lonicerae 4-9g Herba Houttuyniae 4-9g
Radix Platycodonis 2-6g Radix Bupleuri 4-9g Radix Scutellariae 8-12g Rhizoma Acori Graminei 2-6g Moschus 0.3-1g.
Beneficial effect of the present invention is: the present invention is based on Basic Theories of Chinese Medicine, in conjunction with clinical practice, and the external pulvis of a kind of pure Chinese crude drug of developing---'Chuierbaoting ' powder.It is held back the liquid antiinflammatory and is the Therapeutic Principle with its heat-clearing and toxic substances removing, has obtained curative effect preferably.The present invention is through long-term clinical practice, has characteristics such as evident in efficacy, safe in utilization, painless, no wound, and economical and practical, make things convenient for common people's medication, it is worth that we promote the use of.
Theory of Chinese medical science is inquired into: the traditional Chinese medical science thinks that otitis media belongs to traditional Chinese medical science " ear " and so on, its symptom heating, otalgia, comes to a head, very then tinnitus, deafness.Because of the Gallbladder Channel of Foot-Shaoyang " its person behind ear pleasant, leave ear before." so the gallbladder meridian wind heat, follow through on disturb, often can cause primary disease.With the key of ear for emptying, be people's minor matters tip, efficacy of a drug difficulty reaches, and treatment difficulty often is difficult for radical cure, so with heat-clearing and toxic substances removing, to hold back the liquid antiinflammatory be the main means for the treatment of otitis media.The present invention adopts pure Chinese crude drugs such as Radix Saposhnikoviae, Fructus Forsythiae, the Radix Angelicae Dahuricae, Flos Lonicerae, Herba Houttuyniae, Radix Platycodonis, Radix Bupleuri, Radix Scutellariae, Rhizoma Acori Graminei, Moschus.Radix Saposhnikoviae, Fructus Forsythiae, Radix Angelicae Dahuricae dispelling wind to relieve the exterior syndrome in the side; Herba Houttuyniae, Flos Lonicerae, Radix Scutellariae heat-clearing and toxic substances removing; Radix Bupleuri, Radix Platycodonis are that the gas medicine is to help the medicine-feeding performance; Rhizoma Acori Graminei, Moschus are awaking drug.The all medicines in full side are the long memorial wind, relieving exterior syndrome altogether, the property of medicine of heat-clearing and toxic substances removing.And all medicines adopt charcoal (calcined) sustainability (except that Moschus), and levigation sieves and is made.Medicated powder has very strong Absorption to the sepage in the ear.Be a kind of wound evident in efficacy, safe in utilization, painless, no, and economical and practical, convenient, the medicine that is worth of widely use.
The specific embodiment
Concrete formulation Example of the present invention is as follows:
Embodiment 1: it is that one-tenth by following weight ratio is distributed into medicament:
Radix Saposhnikoviae 4g Fructus Forsythiae 4g Radix Angelicae Dahuricae 4g Flos Lonicerae 4g Herba Houttuyniae 4g
Radix Platycodonis 2g Radix Bupleuri 4g Radix Scutellariae 8g Rhizoma Acori Graminei 2g Moschus 0.3g.
Embodiment 2: it is that one-tenth by following weight ratio is distributed into medicament:
Radix Saposhnikoviae 9g Fructus Forsythiae 9g Radix Angelicae Dahuricae 9g Flos Lonicerae 9g Herba Houttuyniae 9g
Radix Platycodonis 6g Radix Bupleuri 9g Radix Scutellariae 12g Rhizoma Acori Graminei 6g Moschus 1g.
Embodiment 3: it is that one-tenth by following weight ratio is distributed into medicament:
Radix Saposhnikoviae 5g Fructus Forsythiae 5g Radix Angelicae Dahuricae 5g Flos Lonicerae 5g Herba Houttuyniae 5g
Radix Platycodonis 3g Radix Bupleuri 5g Radix Scutellariae 9g Rhizoma Acori Graminei 3g Moschus 0.5g.
Embodiment 4: it is that one-tenth by following weight ratio is distributed into medicament:
Radix Saposhnikoviae 6g Fructus Forsythiae 6g Radix Angelicae Dahuricae 6g Flos Lonicerae 6g Herba Houttuyniae 6g
Radix Platycodonis 4g Radix Bupleuri 6g Radix Scutellariae 10g Rhizoma Acori Graminei 4g Moschus 0.7g.
Embodiment 5: it is that one-tenth by following weight ratio is distributed into medicament:
Radix Saposhnikoviae 7g Fructus Forsythiae 7g Radix Angelicae Dahuricae 7g Flos Lonicerae 7g Herba Houttuyniae 7g
Radix Platycodonis 5g Radix Bupleuri 7g Radix Scutellariae 11g Rhizoma Acori Graminei 5g Moschus 0.9g.
The present invention is made up of pure Chinese crude drugs such as Radix Saposhnikoviae, Fructus Forsythiae, the Radix Angelicae Dahuricae, Flos Lonicerae, Herba Houttuyniae, Radix Platycodonis, Radix Bupleuri, Radix Scutellariae, Rhizoma Acori Graminei, Moschus, and adopts conventional modern Chinese medicine manufacturing technology through charcoal (calcined) sustainability (except that Moschus), and levigation sieves and is made.
Get 0.05g medicated powder when the present invention uses and include in the blowpipe, aim at earhole and be blown into fast, make its medicated powder be uniformly distributed in ear, play sepage in the ear, the effect of eliminating inflammation and expelling toxin of absorbing.
After being blown into medicated powder, slightly suffocation sense temporarily in the ear, but do not need to process in addition.Because medicated powder has very strong dampness effect, the ear Chinese medicine powder drops out voluntarily with dry and hard after a few days.Because most of patients once can be cured as long as use.The person of once not healing needs carefully clear up in ear with cotton swab, just can execute secondary again and be blown into.
Therapeutic outcome of the present invention:
Efficacy assessment standard of the present invention is:
Cure: clinical symptom disappearance, conscious auditory rehabilitation, the tympanum color is normal, and it is normal that the tympanum curve recovers:
Produce effects: cardinal symptom and sign are clearly better, and check no abnormal discovery.
Effectively: cardinal symptom and sign have improvement, check and before take a favorable turn.
Invalid: clinical symptoms and sign do not see and alleviate that every inspection does not have significant change.
Below all medical records all from prosperous subhealth state institute of week, case is collected and to be lasted for two years.80 routine otitis media patients amount to 141 ears.Man's 58 examples, women 22 examples.12~51 years old age, 32 years old mean age, the course of disease 2 months~3 years.Suppurative otitis media 31 examples wherein, secretory otitis media 49 examples.
All patients all accept " 'Chuierbaoting ' powder " treatment, among the 80 routine patients, once can cure as long as use for patients with mild; Once do not heal for middle severe patient, behind the cleaning in ear, execute secondary again and be blown into treatment; After 5 times, 57 examples of healing account for 71.2% so repeatedly; 12 examples of produce effects account for 15.0%; Effective 7 examples account for 8.8%; 4 invalid examples account for 5.0%.

Claims (6)

1. 'Chuierbaoting ' powder is characterized in that: it is that one-tenth by following weight ratio is distributed into medicament:
Radix Saposhnikoviae 4-9g Fructus Forsythiae 4-9g Radix Angelicae Dahuricae 4-9g Flos Lonicerae 4-9g Herba Houttuyniae 4-9g
Radix Platycodonis 2-6g Radix Bupleuri 4-9g Radix Scutellariae 8-12g Rhizoma Acori Graminei 2-6g Moschus 0.3-1g.
2. according to the described 'Chuierbaoting ' powder of claim 1, it is characterized in that: it is that one-tenth by following weight ratio is distributed into medicament:
Radix Saposhnikoviae 4g Fructus Forsythiae 4g Radix Angelicae Dahuricae 4g Flos Lonicerae 4g Herba Houttuyniae 4g
Radix Platycodonis 2g Radix Bupleuri 4g Radix Scutellariae 8g Rhizoma Acori Graminei 2g Moschus 0.3g.
3. according to the described 'Chuierbaoting ' powder of claim 1, it is characterized in that: it is that one-tenth by following weight ratio is distributed into medicament:
Radix Saposhnikoviae 9g Fructus Forsythiae 9g Radix Angelicae Dahuricae 9g Flos Lonicerae 9g Herba Houttuyniae 9g
Radix Platycodonis 6g Radix Bupleuri 9g Radix Scutellariae 12g Rhizoma Acori Graminei 6g Moschus 1g.
4. according to the described 'Chuierbaoting ' powder of claim 1, it is characterized in that: it is that one-tenth by following weight ratio is distributed into medicament:
Radix Saposhnikoviae 5g Fructus Forsythiae 5g Radix Angelicae Dahuricae 5g Flos Lonicerae 5g Herba Houttuyniae 5g
Radix Platycodonis 3g Radix Bupleuri 5g Radix Scutellariae 9g Rhizoma Acori Graminei 3g Moschus 0.5g.
5. according to the described 'Chuierbaoting ' powder of claim 1, it is characterized in that: it is that one-tenth by following weight ratio is distributed into medicament:
Radix Saposhnikoviae 6g Fructus Forsythiae 6g Radix Angelicae Dahuricae 6g Flos Lonicerae 6g Herba Houttuyniae 6g
Radix Platycodonis 4g Radix Bupleuri 6g Radix Scutellariae 10g Rhizoma Acori Graminei 4g Moschus 0.7g.
6. according to the described 'Chuierbaoting ' powder of claim 1, it is characterized in that: it is that one-tenth by following weight ratio is distributed into medicament:
Radix Saposhnikoviae 7g Fructus Forsythiae 7g Radix Angelicae Dahuricae 7g Flos Lonicerae 7g Herba Houttuyniae 7g
Radix Platycodonis 5g Radix Bupleuri 7g Radix Scutellariae 11g Rhizoma Acori Graminei 5g Moschus 0.9g.
CN2007101441035A 2007-12-25 2007-12-25 'Chuierbaoting' powder Expired - Fee Related CN101209322B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2007101441035A CN101209322B (en) 2007-12-25 2007-12-25 'Chuierbaoting' powder

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2007101441035A CN101209322B (en) 2007-12-25 2007-12-25 'Chuierbaoting' powder

Publications (2)

Publication Number Publication Date
CN101209322A true CN101209322A (en) 2008-07-02
CN101209322B CN101209322B (en) 2010-08-25

Family

ID=39609686

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2007101441035A Expired - Fee Related CN101209322B (en) 2007-12-25 2007-12-25 'Chuierbaoting' powder

Country Status (1)

Country Link
CN (1) CN101209322B (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101396533B (en) * 2008-10-09 2011-01-26 刘运波 Traditional Chinese medicine for treating acute catarrhal otitis media
CN102000194A (en) * 2010-11-15 2011-04-06 杨兆科 Traditional Chinese medicine composition for treating tympanitis and preparation method thereof
CN102657705A (en) * 2012-05-22 2012-09-12 王永红 Medicine for treating tympanitis and preparation method thereof
CN115177697A (en) * 2022-07-28 2022-10-14 殷竹君 Traditional Chinese medicine preparation for treating intractable otitis media and preparation method thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1323673C (en) * 2004-03-30 2007-07-04 沈惠明 Medicinal formulation for treating upper respiratory track infection and its design method

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101396533B (en) * 2008-10-09 2011-01-26 刘运波 Traditional Chinese medicine for treating acute catarrhal otitis media
CN102000194A (en) * 2010-11-15 2011-04-06 杨兆科 Traditional Chinese medicine composition for treating tympanitis and preparation method thereof
CN102000194B (en) * 2010-11-15 2012-06-27 杨兆科 Traditional Chinese medicine composition for treating tympanitis and preparation method thereof
CN102657705A (en) * 2012-05-22 2012-09-12 王永红 Medicine for treating tympanitis and preparation method thereof
CN115177697A (en) * 2022-07-28 2022-10-14 殷竹君 Traditional Chinese medicine preparation for treating intractable otitis media and preparation method thereof

Also Published As

Publication number Publication date
CN101209322B (en) 2010-08-25

Similar Documents

Publication Publication Date Title
CN103405596A (en) Traditional Chinese medicine for treating sinusitis
CN104352587A (en) Ointment for treating rhinitis
CN101549113A (en) Traditional Chinese medicine composition for treating urinary system stones and preparation method thereof
CN101209322B (en) 'Chuierbaoting' powder
CN101129636A (en) Medicine for treating nasal inflammation
CN101979022A (en) Chinese medicinal mixture for treating chronic rhinitis
CN101961388B (en) Balneation effervescent tablet for preventing heat type common cold
CN102091250B (en) Traditional Chinese medicine for treating acute tonsillitis
CN105012585A (en) Traditional Chinese medicine for treating rhinitis
CN101773601B (en) Throat-care granules in bag for treatment of pharyngitis
CN1320895C (en) Rhinitis treating Chinese medicine prepn
CN102526236B (en) Pharmaceutical formulation for treating influenza and preparation method thereof
CN108126066A (en) A kind of capsule medicine and preparation method for treating rhinitis chronic
CN105998840A (en) External use ointment used for treating insect bite dermatitis and preparation method
CN102657709A (en) A traditional Chinese medicine for treating rhinitis
CN102068511A (en) External medicament for treating lumbar vertebral disc protrusion
CN104825626A (en) Medicine for treating frontal sinusitis
CN1218733C (en) Medicine for treating common cold and preparation method
CN104666516A (en) Anti-inflammatory leucorrhoea arresting washing liquor
CN115040613B (en) Traditional Chinese medicine composition for improving fever symptoms of viral influenza, application and preparation
CN103638098A (en) Tibetan medicinal composition for treating respiratory tract disease as well as preparation and use methods thereof
CN103285169A (en) Traditional Chinese medicine pill for treatment of chronic rhinitis
CN101732584B (en) Throat disinhibiting bagged soaking preparation for treating pharyngitis
CN102284035A (en) Chinese composition for treating rhinitis
CN101152361A (en) Traditional Chinese medicine for treating chronic simple rhinitis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20100825

Termination date: 20121225